*
Corresponding authors
a
Department of Chemistry, RCSI University of Medicine and Health Sciences, 123 St. Stephens Green, Dublin 2, Ireland
E-mail:
andreasheise@rcsi.ie
b
Department of Bioengineering, University of California, Los Angeles, Los Angeles, CA 90095-1600, USA
c
Center for Minimally Invasive Therapeutics (C-MIT), University of California, Los Angeles, Los Angeles, CA 90095-1600, USA
d
California NanoSystems Institute (CNSI), University of California, Los Angeles, Los Angeles, CA 90095-1600, USA
e
Department of Materials Science and Engineering, Tokyo Institute of Technology, Yokohama, Japan
f
Drug Delivery & Advanced Materials Team, School of Pharmacy, RCSI University of Medicine and Health Sciences, 123 St. Stephens Green, Dublin 2, Ireland
g
Centre for Research in Medical Devices (CURAM), RCSI University of Medicine and Health Sciences, and National University of Ireland, Dublin 2, Galway, Ireland
h
Advanced Materials and Bioengineering Research Centre (AMBER), RCSI University of Medicine and Health Sciences and Trinity College Dublin, Dublin 2, Ireland
i
Department of Clinical Microbiology, RCSI University of Medicine and Health Sciences, Education and Research Centre, Beaumont Hospital, Dublin 9, Ireland
j
Department of Chemical and Biomolecular Engineering, University of California, Los Angeles, 5531 Boelter Hall, Los Angeles, CA 90095, USA
k
Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, 10833 Le Conte Ave, Los Angeles, CA 90095, USA
l
Terasaki Institute for Biomedical Innovation, Los Angeles, California 90024, USA
m
Department of Chemical Engineering, The Pennsylvania State University, University Park, PA 16802, USA
E-mail:
sheikhi@psu.edu